14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
On January 7, 2020, the U.S. Department of Labor’s Wage and Hour Division (WHD) issued three opinio...
Read More >
Join Partners Anne Domozick and Forbes Thompson to gain insights on the lessons learned when negotia...
Read More >
In late 2018, in Sulyma v. Intel Corporation Investment Policy Committee, the Ninth Circuit Court of...
Read More >
In CHS/Community Health Systems, Inc. et al v. Steward Health Care System LLC, the Delaware Court of...
Read More >
New Jersey Governor Phil Murphy just issued an executive order lifting some of the existing restrict...
Read More >
On May 17, 2019, Illinois Governor Pritzker signed legislation eliminating the state’s 25-year stat...
Read More >